Skip to main content
. 2017 Nov 16;135(12):1376–1385. doi: 10.1001/jamaophthalmol.2017.4859

Table 2. Pathogenic or Likely Pathogenic Mutations Identified in 28 Patients With Infantile Nystagmus Syndrome.

Patient No. Initial Diagnosis Gene Zygosity Mutations Segregation Analysis ExAC
(MAF)
In Silico Prediction (FATHMM) Previous
Literature
Accession ID for Transcripta
1 LCA GUCY2D Compound; heterozygous c.1978C>T: p.Arg660Ter; c.3038G>A: p.Gly1013Glu Paternal; maternal 0.0002;
none
NA;
D (–2.12)
Reference17;
novel
NM_000180.3
2b LCA GUCY2D Compound; heterozygous c.1991A>C: p.His664Pro; c.2649delT: p.Phe883LeufsTer13 Paternal; maternal None;
none
D (–1.86);
NA
Novel;
novel
NM_000180.3
3 LCA GUCY2D Homozygous c.2649delT: p.Phe883LeufsTer13 NA None NA Novel NM_000180.3
4b LCA GUCY2D Compound; heterozygous c.2649delT: p.Phe883LeufsTer13; c.3038G>A: p.Gly1013Glu Paternal; maternal None;
none
NA;
D (–2.12)
Novel;
novel
NM_000180.3
5 LCA GUCY2D Compound; heterozygous c.2818C>T: p.Arg940Trp; c.3038G>A: p.Gly1013Glu Paternal; maternal 0.0000083;
none
D (–1.55);
D (–2.12)
Novel;
novel
NM_000180.3
6b LCA NMNAT1 Compound; heterozygous c.196C>T: p.Arg66Trp; c.709C>T: p.Arg237Cys Maternal; paternal 0.00013;
0.000074
D (–6.60);
D (–4.67)
References18,19;
references18,19,20
NM_022787.3
7b LCA NMNAT1 Compound; heterozygous c.196C>T: p.Arg66Trp; c.709C>T: p.Arg237Cys Maternal; paternal 0.00013;
0.000074
D (–6.60);
D (–4.67)
References18,19;
references18,19,20
NM_022787.3
8 LCA NMNAT1 Compound; heterozygous c.709C>T: p.Arg237Cys;
exon 4, 5 deletion
Paternal; maternal 0.000074;
none
D (–4.67);
NA
References18,19,20;
reference21
NM_022787.3
9 LCA RPGRIP1 Compound; heterozygous c.2302C>T: p.Arg768Ter; c.3565_3571del: pArg1189GlyfsTer7 Paternal; maternal 0.000039;
0.000017
NA;
NA
Novel;
reference22
NM_020366.3
10 IIN RPGRIP1 Homozygous c.3565_3571del: p.Arg1189GlyfsTer7 NA 0.000017 NA Reference22 NM_020366.3
11 LCA CEP290 Compound; heterozygous c.1666delA: p.Ile556PhefsTer17; c.6012-12T>A Maternal; paternal 0.0142;
0.000025
NA;
0.25177
References23,24;
references24,25
NM_025114.3
12b LCA CEP290 Compound; heterozygous c.-1G>A; c.6012-12T>A Paternal; maternal 0.0000089;
0.000025
0.90875;
0.25177
Novel;
references24,25
NM_025114.3
13 IIN CRB1 Compound; heterozygous c.1208C>G: p.Ser403Ter; c.1576C>T: p.Arg526Ter Paternal; maternal None;
none
NA; NA Reference26;
reference23
NM_201253.2
14b LCA CRX Heterozygous c.442delG: p.Gly148AlafsTer39 De novo None NA Novel NM_000554.5
15 LCA WDR19 Homozygous c.3533G>A: p.Arg1178Gln NA 0.00058 Tolerated;
(–0.91)
Reference27 NM_025132.3
16 OA GPR143 Hemizygous c.514G>C: p.Gly172Arg NA None D (–6.09) Novel NM_000273.2
17 IIN GPR143 Hemizygous c.659-3C>G NA None 0.90355 Novel NM_000273.2
18 OA GPR143 Hemizygous Exon 2, 3 deletion NA None NA Reference28 NM_000273.2
19 OA GPR143 Hemizygous Exon 2, 3 deletion NA None NA Reference28 NM_000273.2
20 IIN PAX6 Heterozygous c.113G>C: p.Arg38Pro NA None D (–6.36) Novel NM_000280.4
21 PAX6 PAX6 Heterozygous c.622C>T: p.Arg208Trp NA 0.0000082 D (–3.83) References29,30 NM_000280.4
22 PAX6 PAX6 Heterozygous c.782G>T: p.Arg261Leu NA None D (–4.43) Novel NM_000280.4
23 IIN PAX6 Heterozygous c.1088C>A: p.Ser363Ter NA None NA Novel NM_000280.4
24 ACHM CNGA3 Compound; heterozygous c.1262delA: p.Lys421SerfsTer44; c.1642G>A: p.Gly548Arg Paternal; maternal None;
0.000025
NA;
D (–6.35)
Novel;
novel
NM_001298.2
25 ACHM CNGB3 Homozygous c.1928 + 2T>C NA None 0.99601 Novel NM_019198.4
26 IIN FRMD7 Heterozygous c.901T>C: p.Tyr301His NA None D (–4.63) Novel NM_194277.2
27 IIN FRMD7 Hemizygous c.910C>T: p.Arg304Ter NA None NA References18,31,32 NM_194277.2
28 IIN CACNA1F Hemizygous c.342delC: p.Phe115SerfsTer22 Maternal None NA Novel NM_005183.2

Abbreviations: ACHM, achromatopsia; D, damaging; ExAC, Exome Aggregation Consortium; FATHMM, functional analysis through hidden Markov models; IIN, idiopathic infantile nystagmus; LCA, Leber congenital amaurosis; MAF, minor allele frequency; NA, not available; OA, ocular albinism.

a

NM numbers were the accession identification numbers for longest transcript of the gene provided by Ensembl.

b

Previously reported with different next-generation sequencing methods using clinical exome sequencing (TruSight One sequencing panel).33